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Because dinucleotides are signaling molecules that can inter-
act with cell surface receptors and regulate the rate of muco-
ciliary clearance in lungs, we studied their metabolism by using
human airway epithelial cells. A membrane-bound enzyme
was detected on the mucosal surface of polarized epithelia
that metabolized dinucleotides with a broad substrate speci-














 2 to 6). The enzymatic reaction yielded nu-
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-nitrophenyl ester and adenosine diphosphate (ADP)-
ribose, substrates of ecto alkaline phosphodiesterase I (PDE I)
activities, were also hydrolyzed by the apical surface of airway




























affected by inhibitors of cyclic nucleotide phosphodiesterases










-ethylmaleimide. These results suggest that a PDE I is re-
sponsible for the hydrolysis of extracellular dinucleotides in
human airways. The wide substrate specificity of PDE I sug-
gests that it may be involved in several signaling events on
the luminal surface of airway epithelia, including purinoceptor














 2 to 6) are now
widely accepted as a novel class of extracellular signaling
molecules that exhibit autocrine and paracrine functions
through the activation of cell surface receptors (1–3). Ac-
tivities ascribed to dinucleotides include modulation of plate-






















 receptor (6). In air-













increased cilia beating frequency, and mucus secretion,
functions important for mucociliary clearance (7).
The degree of phosphorylation of a dinucleotide is a key
variable in determining the cellular responses to this class









































































vasoconstriction (8). Dinucleotides also reduced the elec-






































































) (9). In the guinea pig right atrium,





































A and ATP were sensitive to

















 purinoceptor antagonist (10).
These studies suggest that, depending on the phosphoryla-













 purinoceptor activation may
require conversion of the dinucleotide into adenosine by
cell surface enzymes.
The metabolism of extracellular dinucleotides has been
reported at the surface of vascular endothelial cells (11–




 electric organ (16). These enzyme activities cata-


























 2 to 6) in the presence of divalent cat-









Recent studies suggest that these ectoenzymes may belong
to a family of glycoproteins designated as ecto alkaline
phosphodiesterase I (PDE I). Several PDE I isoforms
have been cloned and detected in mammalian tissues, in-
cluding the brain, heart, intestines, liver, lungs, and vascu-
lar system (17–25). These proteins play important roles
under normal and pathologic conditions, such as myelin
sheath formation in the brain (21) and initiation of tumor
metastasis (23). They cleave phosphodiester bonds of nu-









ester (TMP-pnp), as well as pyrophosphate bonds of nu-
cleotides like nicotinamide adenine dinucleotide (NAD),
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A; adenosine triphosphate, ATP; ADP-ribosyl transferase,
ART; cyclic AMP, cAMP; cyclic guanosine monophosphate, cGMP; cy-
tidine triphosphate, CTP; 1,3-dipropyl-8-p-sulfophenylxanthine, DPSPX;
guanidine triphosphate, GTP; high performance liquid chromatography,









; Krebs buffer, KRB; 8-methoxymethyl-3-isobutyl-1-





ethylmaleimide, NEM; phosphodiesterase I, PDE I; tetrabutyl ammonium













-sulfophenyl)theophylline, 8-pSPT; uridine diphos-






















AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL. 23 2000
 
phate sugars (uridine diphosphate glucose and ADP-ribose)
(17, 18, 24–27). Dinucleotides were reported as substrates
for PDE I purified from human plasma (28), rat liver (29),
and rat C6 glioma (30). In contrast, these purified PDE I
showed little or no activity towards RNA, adenosine
monophosphate (AMP), or cyclic AMP (cAMP) (24, 26,
28, 29). In this study, we report for the first time the me-
tabolism of extracellular dinucleotides on the apical mem-
brane of human airway epithelial cells. We also provide
biochemical evidence that the enzyme that mediates this






Well-differentiated cultures from passage 1 human airway epi-
thelial cells were grown as previously described (31). In brief, na-
sal and bronchial cells were harvested from resected surgical spe-
cimens (32). Primary cells were isolated by protease digestion
and plated on a collagen-coated tissue culture dish (5 to 10 d) in
LHC9 medium (33) containing 25 ng/ml epidermal growth factor
(EGF), 50 nM retinoic acid, 40 
 
mg/ml gentamicin, 0.5 mg/ml bo-
vine serum albumin, 0.8% bovine pituitary extract, 50 U/ml peni-
cillin, 50 mg/ml streptomycin, and 0.125 mg/ml amphotericin,
termed bronchial epithelial growth medium (BEGM). The cells
were trypsinized and subpassaged on porous Transwell Col filters
(diameters: well, 24 mm; pore, 0.45 mM) in an air–liquid interface
(ALI) medium. ALI was similar to BEGM, except for a 50:50
mixture of LHC basal and Dulbecco’s modified Eagle’s medium-
high glucose as the base, amphotericin and gentamicin were omit-
ted, and EGF concentration was reduced to 0.5 ng/ml. Enzyme as-
says were carried out 4 to 5 wk after the cells reached confluence.
The cultures were composed mainly of ciliated cells (. 90%) and
exhibited a transepithelial electrical resistance of at least 300 V/cm2.
Lactate dehydrogenase activity was employed as a test of cellular
integrity.
Dinucleotide Hydrolase Assays
The cell surfaces were rinsed three times with Krebs buffer (KRB
[in mM]): 140 Na1, 120 Cl2, 5.2 K1, 25 HCO32, 2.4 HPO42, 1.3
Ca21, 1.3 Mg21, 5.2 glucose, and 25 N-2-hydroxyethylpiperazine-
N9-ethane sulfonic acid (Hepes) (pH 7.4); and then pre-incubated
30 min in KRB (0.35 ml apical/2 ml basolateral) at 378C (5%
CO2/95% O2). The enzyme reaction was initiated by nucleotide
addition (0.1 mM, unless stated otherwise) and stopped by trans-
ferring 25-ml aliquots to tubes containing 0.3 ml ice-cold water.
The samples were boiled for 3 min, filtered, and analyzed by re-
versed-phase, paired-ion high performance liquid chromatogra-
phy (HPLC). For the determination of optimum pH, Hepes was
used to buffer solutions at pH 6.5 to 8.0, Tricine for solutions at
pH 8.0 and 8.5, and 2-[N-cyclohexylamino]ethanesulfonic acid
(CHES) for solutions at pH 8.5 and 9.0. In these buffers, bicar-
bonate was omitted for a better control of pH.
Enzyme Kinetics and Competition Assays
The kinetic parameters of dinucleotide metabolism by human
bronchial epithelial cells were measured with [3H]Up4U (P1,P4-
di[uridane-59]tetraphosphate). A diuridine nucleotide was cho-
sen over a diadenosine nucleotide because of the availability of
the tritiated form [3H]Up4U, which was generously provided by
Inspire Inc. (Durham, NC). Competition assays were conducted
with ADP-ribose and Up4U, as substrates for PDE I and ApnA
hydrolase activities, respectively. The choice of ADP-ribose over
TMP-pnp reflected its higher specificity for PDE I, as well as the
convenience of monitoring the reaction by HPLC. Under these
conditions, the metabolites of the two substrates could be distin-
guished on the HPLC tracings. The reactions were initiated by
the addition of the two substrates previously mixed. All kinetic
and competition assays were performed as stated previously for
the dinucleotide hydrolase assays and in the presence of 5 U of
commercial alkaline phosphatase to avoid enzyme inhibition by
products of the reaction. We verified that dinucleotides and
ADP-ribose were not substrates of alkaline phosphatase.
PDE I Assays
PDE I activity was measured using a modification of the method
of Kelly and Butler (34). The epithelial surfaces were rinsed three
times with KRB and then pre-incubated 30 min at 378C with the
same buffer (0.35 ml apical/2 ml basolateral). The enzyme reac-
tion was initiated with 1 mM TMP-pnp and stopped by transfer-
ring an aliquot of 250 ml into a tube containing 25 ml of NaOH
10 mM. Absorbance was read at 405 nm, and the enzyme activity
was quantified with a standard curve for p-nitrophenol. PDE I ac-
tivity was also measured with ADP-ribose under the conditions
mentioned previously for the dinucleotide hydrolase assays.
HPLC Analysis
The separation system consisted in a Dinamax C-18 column and a
mobile phase developed with buffer A (10 mM KH2PO4 and 8 mM
tetrabutyl ammonium hydrogen sulfate [TBASH], pH 5.3) from 0
to 15 min, buffer B (100 mM KH2PO4, 8 mM TBASH, and 10%
MeOH, pH 5.3) from 15 to 50 min, and buffer A from 50 to 60
min. Absorbance was monitored at 254 nm with an on-line model
490 multiwavelength detector (Shimadzu Scientific Instruments
Inc., Norcross, GA), and radioactivity was determined on-line
with a Flo-One Radiomatic b detector (Packard, Canberra, Aus-
tralia), as described previously (6).
Statistics
All enzyme assays were performed on cultures of differentiated
nasal or bronchial epithelial cells obtained from at least three dif-
ferent donors (n > 3). Rates of hydrolysis were calculated from
the decrease in the amount of substrate monitored by HPLC and
presented as nmoles/min ? cm2 of surface area. These values were
expressed as means 6 standard error of the mean (SEM). Unpaired
Student’s t tests were used to assess the significance between means.
Paired t tests were used when comparing hydrolysis rates measured
on the apical and basolateral sides of the same epithelium. All lin-
ear regressions, curve fits, and data transformations were per-
formed with PC computer programs Origin and Sigma plot.
Materials
ADP-ribose, alpha,beta methylene ATP (a,bmetATP), Ap2A,
Ap3A, Ap4A, Ap5A, Ap4, 39,59-cyclic guanosine monophosphate,
3959cAMP, 1,3-dipropyl-8-p-sulfophenylxanthine (DPSPX), 3-iso-
butyl-1-methylxanthine (IBMX), 8-methoxymethyl-3-isobutyl-1-
methylxanthine (mmIBMX), NAD, TMP-pnp, N-ethylmaleimide
(NEM), Ro 20-1724, sodium fluoride, and TBASH were obtained
from Sigma (St. Louis, MO). Mononucleotides and calf intestine
alkaline phosphatase were purchased from Boehringer (Man-
nheim, Germany). Tritium-labeled Up4U (1 mCi/mmol) and
UpnU (n 5 2 to 6) were generously provided by Inspire, Inc. All
other reagents were of analytical grade.
Results
Distribution of Dinucleotide Hydrolase Activity in
Human Airways
The metabolism of extracellular dinucleotides was first de-
tected upon addition of 0.1 mM Ap4A to the apical surface
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of human airway epithelial cells (Figure 1). The enzyme
activity was higher on bronchial (0.12 6 0.01 nmoles ? min21 ?
cm22) than on nasal (0.07 6 0.01 nmoles ? min21 ? cm22)
cells. In contrast, Ap4A was not hydrolyzed by the basolat-
eral surfaces of either cell type over a 60-min incubation.
The protein responsible for Ap4A hydrolysis in human air-
ways is an ectoenzyme for the following reasons: (1) the
substrate was hydrolyzed by intact cells and the products
were released in the extracellular milieu; (2) the amount of
substrate hydrolyzed over 60 min followed a linear rela-
tionship over time, making it unlikely that a significant
amount of the substrate had been hydrolyzed after enter-
ing the cells; and (3) the rate of Ap4A hydrolysis measured
in buffer, collected after 60 min of incubation on the cells,
corresponded to less than 4% of the total cell surface en-
zyme activity (data not shown). Thus, human airway epi-
thelial cells possess a membrane-bound ecto dinucleotide
hydrolase activity located on the apical surface.
Substrate Specificity and Mode of Action
The metabolism of ApnA on human bronchial epithelial
cells was examined by HPLC. Representative chromato-
graphic profile sets obtained for Ap3A, Ap4A, and Ap5A
after 0, 20, and 40 min of incubation on the cells are shown
in Figure 2. The major products of Ap3A hydrolysis were
ADP and adenosine. The mass of AMP remained very
small throughout the incubation period, probably due to
the high rate of degradation by an ecto-59-nucleotidase. In
the case of Ap4A, the major peaks were ADP and adeno-
sine, with small peaks of AMP and ATP. The presence of
ATP suggests that the enzyme cleaved Ap4A into ATP
and AMP, and not into two ADPs. Finally, the metabolism
of Ap5A led to the accumulation of Ap4, and smaller
amounts of ATP, ADP, AMP, and adenosine. Altogether,
these results demonstrate that the ectoenzyme proceeds
by an asymmetrical mode of cleavage, with AMP and
Apn21 as products of the reaction.
Human airway epithelial cells hydrolyzed both diaden-
osine and diuridine polyphosphates bearing two to six phos-
phate groups (Figures 3A and 3B). Diadenosine polyphos-
phates were hydrolyzed on average 20% more rapidly than
diuridine polyphosphates, when values were compared for
dinucleotides containing the same number of phosphates.
In addition, the rates of hydrolysis were inversely related
to the length of the phosphate chain.
We conducted a series of experiments to investigate
whether the relationship between phosphate chain length
and hydrolysis rates could be explained by product inhibi-
tion. First, addition of commercial alkaline phosphatase
(5 U) to efficiently remove any nucleotide formed during
the reaction accelerated the metabolism of [3H]Up4U
(Figure 3C). We verified that alkaline phosphatase had no
hydrolytic activity toward dinucleotides in vitro (data not
Figure 1. Distribution of dinucle-
otide hydrolase activity in human
airways. Ap4A hydrolysis was mea-
sured on the apical (squares) and
basolateral (circles) surfaces of hu-
man nasal (closed symbols) and
bronchial (open symbols) epithelial
cells. Assays were conducted in
KRB (pH 7.4) with 0.1 mM Ap4A,
and aliquots of 25 ml were collected over 60 min to be analyzed
by HPLC. No hydrolytic activity was detected on basolateral sur-
faces. On apical surfaces, Ap4A hydrolysis rates were signifi-
cantly higher with bronchial cells than with nasal cells (paired t
test: t 5 3.5, n 5 4).
Figure 2. HPLC profiles of the time-dependent hydrolysis of (A)
Ap3A, (B) Ap4A, and (C) Ap5A by human bronchial epithelial
cells. Assays were conducted in KRB (pH 7.4) with 0.1 mM sub-
strates. Aliquots (25 ml) of apical buffer were collected after 0, 20,
and 40 min of incubation, and analyzed by HPLC. The results are
representative of three to four independent experiments.
Figure 3. Substrate specificity of the dinucleotide hydrolase ac-
tivity on human bronchial epithelial cells. Rates of hydrolysis for
(A) ApnA and (B) UpnU increased significantly with the number
of phosphates (t 5 2.4 to 3.9, P , 0.05) and were 18 6 3% higher
for ApnA over UpnU of equal number of phosphate groups (t 5
2.2 to 3.4, P , 0.05, n 5 5 to 7). Assays were conducted as de-
scribed in MATERIALS AND METHODS. (C, D) Inhibition of dinucle-
otide hydrolysis by mononucleotides. Assays were conducted with
0.1 mM [3H]Up4U (0.1 mCi) and (C) 0.1 mM UTP, UDP, UMP,
or alkaline phosphatase (Alk. Phos., 5 U), and (D) 0.1 mM
a,bmetATP, ATP, UTP, GTP, CTP, or alkaline phosphatase
(Alk. Phos., 5 U). Student’s t tests: UTP . UDP . UMP, and
a,bmetATP . ATP > UTP . GTP . CTP (t 5 3.3 to 4.7, P ,
0.05; n 5 5 to 6; SEM , 5% of the mean).
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shown). Second, addition of 0.1 mM uridine nucleotides
decreased the rate of 0.1 mM [3H]Up4U hydrolysis in the
order of potency: uridine triphosphate (UTP) . uridine
diphosphate (UDP) . uridine monophosphate (UMP)
(Figure 3C). These results show that the rate of hydrolysis
of dinucleotides was inversely related to the degree of
phosphorylation of the mononucleotides. Third, we tested
whether other nucleoside triphosphates could affect the
rate of [3H]Up4U hydrolysis. All nucleotides slowed
[3H]Up4U hydrolysis in the order of potency: a,bmetATP .
ATP > UTP . guanidine triphosphate (GTP) . cytidine
triphosphate (CTP) (Figure 3D). Together, these results
demonstrate that the rate of dinucleotide hydrolysis was
limited by product inhibition. Consequently, most endoge-
nous nucleotides would be expected to modulate the me-
tabolism of extracellular dinucleotides on airway epithelia.
Kinetic Analysis of Dinucleotide Metabolism
The kinetic properties of the ectodinucleotide hydrolase
activity were examined on human bronchial epithelial cells.
The metabolism of [3H]Up4U followed simple Michaelis-
Menten kinetics, and saturation was reached with 1 mM
substrate (Figure 4A). Regression analysis of a Woolf-
Augustinson Hoftsee transformation provided an apparent
Michaelis constant (Km,app) of 22 6 4 mM and an apparent
maximal velocity (Vmax,app) of 0.24 6 0.05 nmoles ? min21 ?
cm22 (Figure 4A, insert). The hydrolysis of [3H]Up4U was
inhibited by Ap2A and Ap6A, with inhibition constant (Ki)
values of 26 6 3 and 19 6 2 mM, respectively. The compet-
itive pattern of inhibition is illustrated by the Dixon plot
obtained with Ap6A (Figure 4B). Because these values are
close to the Km,app calculated for [3H]Up4U, they can be
considered as indirect but accurate estimations of Km,app
for Ap2A and Ap6A. Together, these results suggest that a
single enzyme would be responsible for the metabolism of
diadenosine and diuridine polyphosphates on human air-
way epithelial cells.
Effects of Cations and pH on Ap4A Hydrolysis
The metabolism of extracellular dinucleotides by human
airway epithelial cells requires the presence of divalent
cations. Ap4A hydrolysis measured in KRB containing
1.3 mM Ca21 and 1.3 mM Mg21 was completely abolished
by the addition of 5 mM ethylenediaminetetraacetic acid
(EDTA). Both Mg21 and Ca21 were enzyme activators,
with half-effective concentration (EC50) values of 0.8 and
Figure 4. Kinetic parameters
of the human airway dinucle-
otide hydrolase activity. (A)
Michaelis-Menten relation-
ship for [3H]Up4U hydrolysis.
The reaction was initiated by
the addition of 0.001 to 1 mM
[3H]Up4U (0.1 mCi) in KRB
buffer (pH 7.4) in the pres-
ence of 5 U of commercial
calf intestine alkaline phos-
phatase to prevent inhibition
by reaction products. Ali-
quots (10 ml) of apical buffer
were collected after incuba-
tion periods that limited sub-
strate hydrolysis to less than
10% and were analyzed by
HPLC. Insert: Woolf-Augus-
tinson Hoftsee plot of the sat-
uration curve (r 5 0.99). Cal-
culated Km,app, and Vmax,app values are 22 6 4 mM and 0.24 6 0.05
nmoles ? min21 ? cm22, respectively (n 5 6; SEM , 5% of the mean).
(B) Dixon plot for the competitive inhibition of [3H]Up4U hy-
drolysis by Ap6A. The reaction was started by addition of the two
nucleotides previously mixed together. Aliquots (10 ml) of apical
buffer were collected over 60 min and analyzed by HPLC. The
correlation coefficients (r) were 0.99, 0.97, and 0.99 for 0 (closed
circles), 40 (closed squares), and 100 mM (closed triangles)
[3H]Up4U, respectively (n 5 5, SEM , 7% of the mean).
Figure 5. Effects of cations
and pH on dinucleotide hy-
drolysis by human bronchial
epithelial cells. (A) The ef-
fects of cations on the en-
zyme activity was assayed
with 0.1 mM Ap4A and KRB
buffer (pH 7.4) containing
various concentrations of
Ca21, Mg21, or Mn21. The
zero value was obtained in
the presence of 5 mM EDTA
and standard KRB contain-
ing 1.3 mM Ca21 and 1.3 mM
Mg21. (B) For the pH curve,
different buffers were used to
control pH over 6.5 to 9.5
(see MATERIALS AND METH-
ODS). In both sets of experiments, the reaction was started with
Ap4A, and aliquots (25 ml) of apical buffer were collected over 60
min to be analyzed by HPLC (n 5 4 to 5; SEM , 5% of the
mean).
Figure 6. Metabolism of ADP-
ribose in human airways. (A)
ADP-ribose (ADPR) hydroly-
sis measured on the apical
(squares) and basolateral (cir-
cles) surfaces of human nasal
(closed symbols) and bron-
chial (open symbols) epithe-
lial cells. Assays were con-
ducted in KRB (pH 7.4) with
0.1 mM ADP-ribose, and
buffer aliquots (25 ml) were
collected over 60 min to be
analyzed by HPLC. ADPR
hydrolysis was significantly
faster on bronchial than on
nasal cells, with average val-
ues of 0.14 6 0.01 and 0.04 6
0.01 nmoles ? min21 ? cm22, respectively (paired Student’s t test:
t 5 4.5, n 5 5). (B) Typical HPLC profile obtained for ADPR
hydrolysis by the apical membrane of bronchial cells after 40 min
of incubation. The metabolism of ADPR was monitored by the
production of AMP and adenosine because ribose-5-phosphate
does not absorb in ultraviolet.
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0.4 mM, respectively (Figure 5A). With Mn21, a sharp
peak of activity was reached at about 0.5 mM, whereas
higher concentrations produced lower rates of hydrolysis.
The effect of pH on Ap4A hydrolysis was examined in the
range 6.5 to 9.5 (Figure 5B). The ectoenzyme reached
maximum activity at a pH of 9.0. A threefold increase in en-
zyme activity was observed by raising the pH from 7.5 to 9.0.
Presence of a PDE I on Human Airway Epithelium
Human bronchial epithelial cells hydrolyzed two sub-
strates of PDE I, TMP-pnp (1 mM; 0.07 6 0.01 nmoles ?
min21 ? cm22) and ADP-ribose (1 mM; 0.32 6 0.03 nmoles ?
min21 ? cm22). The metabolism of ADP-ribose was re-
stricted to the apical surface, and the enzyme activity was
higher on bronchial than on nasal cells (Figure 6A). ADP-
ribose hydrolysis led to the production of AMP and ri-
bose-5-phosphate (35). Whereas the latter cannot be de-
tected by ultraviolet absorbance on the HPLC, we moni-
tored the accumulation of AMP and the conversion of the
monophosphate into adenosine (Figure 6B). These results
support the presence of a PDE I activity on airway epithe-
lia that shares the same distribution and asymmetrical
mode of cleavage with the dinucleotide hydrolase activity.
We therefore performed competition studies to investi-
gate whether the same enzyme could be responsible for the
metabolism of dinucleotides and ADP-ribose. The rate of
ADP-ribose hydrolysis was reduced by increasing concen-
trations of Up4U and vice versa (Figures 7A and 7B). The
highest concentration (1 mM) of Up4U (Figure 7A) or ADP-
ribose (Figure 7B) almost completely blocked the reaction
(. 95%), which suggests that a single enzyme hydrolyzed
dinucleotides and ADP-ribose. Dixon plot analysis con-
firmed that ADP-ribose acted as a competitive inhibitor of
Up4U hydrolysis, with a Ki of 23 6 3 mM (Figure 7C).
Table 1 compares the effects of selected inhibitors on
the metabolism of ADP-ribose and Ap4A. The two en-
zyme reactions were similarly inhibited by sodium fluoride
(EC50 ø 0.9 to 1.0 mM) and NEM (EC50 ø 5 mM). Ap4A
and ADP-ribose hydrolysis were not affected by inhibitors
of cyclic nucleotide phosphodiesterases (DPSPX, IBMX,
and Ro 20-1724). In addition, cAMP and cGMP were not
hydrolyzed by nasal or bronchial epithelial cells (data not
shown), which rules out the involvement of an extracellu-
lar cyclic nucleotide phosphodiesterase in the hydrolysis of
ADP-ribose or dinucleotides. Together, these results sug-
gest that a PDE I was responsible for the metabolism of
extracellular diadenosine and diuridine polyphosphates on
the apical membrane of human airway epithelial cells.
Messenger RNA for two PDE I (PC-1 and PD-1b) was de-
tected in human nasal epithelial cells by reverse tran-
scriptase/polymerase chain reaction (data not shown).
Discussion
The initial focus of this study was to investigate the metab-
olism of putative regulators of P2Y2 receptors, dinucle-
otides, by human airway epithelia. Nasal and bronchial ep-
ithelial cells exhibited an ectoenzyme activity that was
restricted to the luminal surface, and that effected an
asymmetrical cleavage of dinucleotides (NpnN; N 5 A or
U) into NMP and Npn21. The mononucleotides derived
from the hydrolysis of Np2N, Np3N, and Np4N were effi-
ciently dephosphorylated into adenosine or uridine by
other ectonucleotidases previously reported on the lumi-
nal surface of airway epithelial cells (36–38). In contrast,
the metabolism of longer dinucleotides (Ap5A and Ap6A)
led to the accumulation of Ap4 and Ap5, suggesting that
highly phosphorylated nucleotides were poor substrates
for ectonucleotidases on airway epithelial cells. Similar
findings have been reported for endothelial cells (11–13).
In contrast, ApnA hydrolysis on chromaffin cells led to the
accumulation of AMP, suggesting that the ecto-59-nucle-
otidase activity was a limiting step in the production of ad-
enosine (14, 15).
The dinucleotide hydrolase activity we measured on
airway epithelia shares several properties with ecto ApnA
hydrolases reported on endothelial cells (11–13), chromaf-
fin cells (14, 15), and Torpedo synaptosomes (16): an asym-
metrical mode of cleavage, a broad substrate specificity,
Figure 7. Competitive inhibi-
tion of ADP-ribose and
Up4U hydrolysis. (A) Time
course of the hydrolysis of
ADP-ribose (ADPR) 0.1 mM
in the presence of [3H]Up4U
(0 [closed circles], 0.1 [open
circles], 0.5 [open squares], or
1.0 [open triangles]; 0.1 mCi).
The reaction was initiated by
addition of the two nucle-
otides previously mixed in the
presence of 5 U of commer-
cial calf intestine alkaline
phosphatase to prevent feed-
back inhibition from reaction
products. Aliquots of 10 ml
were collected over 60 min
and analyzed by HPLC. (B)
Reciprocal experiment with
[3H]Up4U 0.1 mM and
ADPR 0 (closed circles), 0.1
(open circles), 0.5 (open
squares), or 1.0 mM (open tri-
angles). SEM were omitted for clarity (n 5 4 to 6; SEM , 5% of
the mean). (C) Dixon plot for the competitive inhibition of
[3H]Up4U hydrolysis by ADP-ribose. Correlation coefficients for
the linear regressions are 0.95, 0.98, and 0.99 for [3H]Up4U 10
(closed circles), 50 (closed squares), and 100 mM (closed trian-
gles), respectively (n 5 4, SEM , 10% of the mean).
TABLE 1
Effects of inhibitors on Ap4A and ADP-ribose hydrolysis 
by human bronchial epithelial cells
Compounds Ap4A ADP-ribose
Sodium fluoride 54 6 3 50 6 2
NEM 49 6 5 44 6 5
IBMX 104 6 3 102 6 3
mmIBMX 100 6 6 94 6 4
Ro 20-1724 91 6 5 101 6 3
DPSPX 101 6 3 105 6 5
Assays were conducted with 0.1 mM substrate and 1 mM inhibitor, except for
NEM (5 mM). Values are expressed as percent from rates of Ap4A or ADP-
ribose hydrolysis without inhibitors (n 5 4 to 7; SEM , 5% of the mean).
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and inhibition by ATP and ATP analogues. We also
showed that the metabolism of extracellular dinucleotides
on airway epithelia was inhibited by all nucleoside triphos-
phates tested (a,bmetATP . ATP . UTP . GTP .
CTP). Moreover, Up4U hydrolysis was inhibited by uri-
dine nucleotides in the order of potency: UTP . UDP .
UMP. Therefore, the rate of dinucleotide hydrolysis was
inversely related to the degree of phosphorylation of the
products of the reaction. Altogether, these results suggest
that the metabolism of extracellular dinucleotides in vivo
could be modulated by endogenously released or pro-
duced extracellular nucleotides.
The reported dinucleotide hydrolase activities can be
distinguished on the basis of their substrate affinity and
ion sensitivity. The substrate affinity of the airway dinucle-
otide hydrolase falls within the range reported for the por-
cine and bovine aorta endothelial enzymes, with Km values
of 20 mM for Ap3A (11) and 10 mM for Ap4A (12), respec-
tively. The ecto ApnA hydrolases of adrenomedullary en-
dothelial cells (13), chromaffin cells (14, 15), and Torpedo
presynaptic membranes (16) exhibit higher affinities, with
an overall Km/Ki range of 0.5 to 7 mM for Ap2A, Ap3A,
Ap4A, Ap5A, and Ap6A. We also observed that the airway
dinucleotide hydrolase activity required millimolar con-
centrations of divalent cations (Mg21 . Ca21 . Mn21) and
was inhibited by fluoride (IC50 of 1 mM). Whereas these
ionic properties correspond to those of the Torpedo ApnA
hydrolase (16), the endothelial ecto ApnA hydrolases were
inhibited by Ca21 (12, 13), and the chromaffin ecto ApnA
hydrolase was not affected by fluoride (15). Such diversity
in biochemical properties supports the existence of differ-
ent dinucleotide hydrolase isoforms or enzymes.
We therefore performed a series of experiments that
appeared to identify the ectoenzyme responsible for dinu-
cleotide metabolism on human airways as a PDE I. First,
PDE I purified from human plasma (28), rat liver (29),
small intestine, and testis (18) was shown to hydrolyze
NAD, ADP-ribose, ATP, UTP, TMP-pnp, and dinucle-
otides, but not cyclic nucleotides. Human bronchial epi-
thelia exhibited a similar pattern, hydrolyzing dinucle-
otides, TMP-pnp, and ADP-ribose, but not cAMP or
cGMP. Second, the substrate affinity of the purified liver
PDE I for dinucleotides falls within the range we report
for the airway dinucleotide hydrolase, with Km values of
8 to 22 mM for Ap2A, Ap3A, and Ap4A (29). Third, as
we observed on airway epithelia, the rate of dinucleotide
hydrolysis by PDE I was inversely related to the length of
the phosphate chain, and the reaction was inhibited by
a,bmetATP (18). Finally, human plasma (28) and rat liver
(29) PDE I exhibited a pH optimum (8.5 to 9.0) in the
same range as the airway enzyme.
These comparisons strongly suggest the presence of a
PDE I on airway epithelial cells. However, because our
studies were conducted on intact cells, the possibility re-
mained that two distinct enzymes could be responsible for
the metabolism of dinucleotides and ADP-ribose, an ecto
ApnA hydrolase and a PDE I, respectively. To address this
possibility, we tested whether the two substrates competed
for the same catalytic site. Simultaneous addition of Up4U
and ADP-ribose on the apical membrane of human bron-
chial epithelia reduced both rates of hydrolysis. The most
compelling evidence of the presence of a single enzyme
was the nearly complete inhibition (. 95%) of 0.1 mM
Up4U hydrolysis by 1 mM ADP-ribose and vice versa. En-
zyme kinetic analyses indicated that ADP-ribose acted as
a competitive inhibitor for Up4U hydrolysis, with a Ki of
23 mM. Together, these results demonstrate that the ecto-
dinucleotide hydrolase activity we characterized on hu-
man airway epithelia is a PDE I.
In summary, we report for the first time the metabolism
of extracellular dinucleotides on the luminal surface of hu-
man airway epithelia. We also provide biochemical evidence
that this enzyme belongs to the PDE I family, as reported re-
cently for the chromaffin cell ecto dinucleotide hydrolase
(39). The wide substrate specificity of PDE I suggests that
the enzyme may be involved in other signaling events, in ad-
dition to regulating concentrations of purinoceptor agonists.
For instance, PDE I could be involved in the ADP-ribosyla-
tion of cell surface proteins (40). ADP-ribosyl transferases
(ART) use extracellular NAD1 to transfer ADP-ribose to
arginine residues. Removal of AMP from the bound ADP-
ribose by PDE I renders the protein unavailable for further
ribosylation. Reported extracellular ribosylation targets in-
clude the lymphocyte-associated molecule-1 (41) and the ex-
tracellular domain of integrin a7b1 (42). Three members of
the ART family were recently localized on human bronchial
epithelial cells: ART1, ART3, and ART4 (43). Given that
airway epithelia play an active role in inflammatory pro-
cesses by recruiting and interacting with leukocytes and
macrophages, this ART–PDE I enzyme system could be in-
volved in the regulation of immune responses via cell-to-cell
and cell–matrix interactions.
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